Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination

OBJECTIVE: Immunocompromised individuals are at an increased risk of pneumococcal disease. Vaccination is recommended as an important strategy to reduce risk of pneumococcal disease in HIV-infected individuals. This study evaluated the safety and immunogenicity of three 13-valent pneumococcal conjug...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhorat, As’ad E., Madhi, Shabir A., Laudat, France, Sundaraiyer, Vani, Gurtman, Alejandra, Jansen, Kathrin U., Scott, Daniel A., Emini, Emilio A., Gruber, William C., Schmoele-Thoma, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521829/
https://www.ncbi.nlm.nih.gov/pubmed/25888646
http://dx.doi.org/10.1097/QAD.0000000000000689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521829/
https://www.ncbi.nlm.nih.gov/pubmed/25888646
http://dx.doi.org/10.1097/QAD.0000000000000689

Ejemplares similares